MedPath

Ortho-Mcneil Janssen Scientific Affairs LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement

Phase 3
Completed
Conditions
Arthritis
Osteoarthritis, Hip
Osteoarthritis, Knee
Thromboembolism
Interventions
First Posted Date
2010-03-29
Last Posted Date
2017-03-17
Lead Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Target Recruit Count
56
Registration Number
NCT01094886

The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women

Phase 2
Completed
Conditions
Menopause
Hot Flashes
Interventions
First Posted Date
2009-10-07
Last Posted Date
2012-12-12
Lead Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Target Recruit Count
148
Registration Number
NCT00990886

NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain

Phase 3
Completed
Conditions
Pain
Back Pain
Low Back Pain
Back Pain With Radiation
Interventions
First Posted Date
2009-09-29
Last Posted Date
2012-12-19
Lead Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Target Recruit Count
667
Registration Number
NCT00986180

Oxycodone User Registry (OUR)

Completed
Conditions
Pain
Interventions
First Posted Date
2009-09-16
Last Posted Date
2010-04-02
Lead Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Target Recruit Count
827
Registration Number
NCT00978328

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

Phase 4
Terminated
Conditions
Schizophrenia
Interventions
First Posted Date
2009-07-27
Last Posted Date
2012-09-10
Lead Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Target Recruit Count
163
Registration Number
NCT00946985

Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Phase 4
Completed
Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
Drug: Placebo
Drug: Placebo Tablets
First Posted Date
2009-07-10
Last Posted Date
2013-07-30
Lead Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Target Recruit Count
357
Registration Number
NCT00937040

Evaluation of Bacteria in the Mouth and Throat of Healthy Adults Before and After the Administration of Either Levofloxacin or Azithromycin, Both Antibiotic Medications

Phase 1
Completed
Conditions
Healthy Volunteer
First Posted Date
2009-01-13
Last Posted Date
2011-05-19
Lead Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Target Recruit Count
143
Registration Number
NCT00821782

CONCERTA Lab School Study

Phase 4
Completed
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
First Posted Date
2008-12-01
Last Posted Date
2020-03-12
Lead Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Target Recruit Count
89
Registration Number
NCT00799487
© Copyright 2025. All Rights Reserved by MedPath